Tag: Selexis

October 17, 2019 Off

Teneobio, Selexis move to three license deals for multi-specific oncology antibody candidates

GENEVA & NEWARK, Calif.–(BUSINESS WIRE)–Selexis SA and Teneobio, Inc. announced today that they have signed three commercial license agreements (CLAs)…

November 3, 2015 Off

Faron Pharmaceuticals secures Clevegen production with Swiss Selexis

By Dino Mustafić

Finland’s Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company, has entered into an agreement with Swiss-based Selexis SA for producing Novel Cancer Immunotherapy Clevegen.